L. Jacquelyn Sumer's most recent trade in Cullinan Oncology Inc was a trade of 3,756 Common Stock done at an average price of $8.5 . Disclosure was reported to the exchange on Feb. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 3,756 | 136,895 | - | 8.5 | 32,039 | Common Stock |
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 50,000 | 140,651 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 18 Dec 2024 | 3,482 | 90,651 | - | 11.4 | 39,730 | Common Stock |
| Cullinan Oncology Inc | L. Jacquelyn Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jacquelyn Sumer L. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 50,000 | 94,133 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Jacquelyn Sumer L. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 21 Dec 2023 | 1,400 | 44,133 | - | 8.5 | 11,900 | Common Stock |
| Cullinan Oncology Inc | Jacquelyn Sumer L. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.22 per share. | 18 Dec 2023 | 290 | 45,533 | - | 8.2 | 2,384 | Common Stock |
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 20 Jun 2023 | 291 | 45,823 | - | 12.9 | 3,766 | Common Stock |
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 May 2023 | 291 | 46,114 | - | 8.8 | 2,549 | Common Stock |
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 18 Apr 2023 | 290 | 46,405 | - | 10.7 | 3,106 | Common Stock |
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.32 per share. | 20 Mar 2023 | 305 | 46,695 | - | 11.3 | 3,453 | Common Stock |
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 93,500 | 93,500 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jacquelyn L. Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 47,000 | 47,000 | - | 0 | Common Stock |